monomethyl auristatin f mmaf synthetic antineoplastic part approved drug belantamab mafodotin multiple myeloma experimental anticancer antibodydrug conjugates vorsetuzumab mafodotin international nonproprietary names mmafantibodyconjugates name mafodotin refers mmaf plus attachment structure monomethyl auristatin f antimitotic agent inhibits cell division blocking polymerisation tubulin linked antibody high affinity structures cancer cells causing mmaf accumulate mmaf actually desmethylauristatin f nterminal amino group one methyl substituent instead two auristatin f httpsenwikipediaorgwikimonomethylauristatinf